Cell death discovery could lead to next-gen drugs for neurodegenerative conditions Date: May 12, 2025 Source: Walter and Eliza Hall Institute Summary: Researchers have discovered how to block ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research.

Researchers have discovered how to block cells dying, in a finding that could lead to new treatments for neurodegenerative conditions like Parkinson's and Alzheimer's. The team at WEHI ...

Scientists from The University of Manchester have changed our understanding of how cells in living organisms divide, which could revise what students are taught at school. In a study published ...

For over 150 years, scientists have known that wounds alter electric fields across skin cells, says cell biologist Min Zhao of the University of California, Davis School of Medicine. But they didn ...

Fourteen cells from the Arabidopsis thaliana plant were imaged every six minutes for about 24 hours as they regenerated their cell walls.The glow shows cellulose, chains of sugar molecules, which ...

A new study suggests that never-seen-before stem cells in the human retina can restore vision in mice with a common eye disorder. But more work is needed to translate the treatment to people.

Kennedy has made no secret of his support for stem cells, including them in his infamous post on X about FDA's "war on public health" coming to an end. Stem cells were among "suppressed" therapies ...

Amgen and CytomX Therapeutics have kicked a phase 1 T-cell engager to the curb, axing the asset after assessing the clinical data and their pipeline priorities.. CytomX signaled the EGFRxCD3 ...

On February 13, Allogene Therapeutics published new long-term follow-up data on cemacabtagene ansegedleucel, showing the investigative allogeneic chimeric antigen receptor (CAR) T-cell therapy ...

We describe two patients in whom malignant monoclonal T-cell lymphoproliferation developed after administration of chimeric antigen receptor (CAR) T-cell therapy with ciltacabtagene autoleucel ...

These regulators are known as MYB, HDAC2, and FOXA2 and when they were suppressed in colon cancer cells, the cells switched back to a normal-like state, removing the cancer threat without ...